IX(IX)
IX
No analyst ratings available
No analyst price targets available for IX
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $3.87T | $3.62T | $3.78T | $3.95T | $4.16T |
| Low | $3.77T | $3.53T | $3.69T | $3.85T | $4.06T |
| High | $3.94T | $3.68T | $3.84T | $4.02T | $4.23T |
| EBITDA Avg | $1.27T | $1.19T | $1.24T | $1.30T | $1.37T |
| Low | $1.24T | $1.16T | $1.21T | $1.27T | $1.33T |
| High | $1.29T | $1.21T | $1.26T | $1.32T | $1.39T |
| EBIT Avg | $772.21B | $722.20B | $754.41B | $788.69B | $829.88B |
| Low | $753.28B | $704.49B | $735.91B | $769.35B | $809.53B |
| High | $785.49B | $734.62B | $767.38B | $802.26B | $844.16B |
| Net Income Avg | $705.53B | $552.88B | $598.05B | $658.42B | $715.10B |
| Low | $477.45B | $543.44B | $578.99B | $637.43B | $692.30B |
| High | $932.09B | $562.31B | $611.43B | $673.14B | $731.09B |
| EPS Avg | $630.02 | $493.71 | $534.05 | $587.95 | $638.56 |
| Low | $426.35 | $485.28 | $517.02 | $569.21 | $618.21 |
| High | $832.34 | $502.13 | $545.99 | $601.10 | $652.84 |
| Analysts (Rev / EPS) | 2 / 1 | 3 / 1 | 2 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.43T | $998.74B | $696.59B | $841.40B | $860.06B | $878.73B | $897.40B | $977.91B |
| Low | $1.43T | $998.74B | $696.59B | $841.40B | $860.06B | $878.73B | $897.40B | $977.91B |
| High | $1.43T | $998.74B | $696.59B | $841.40B | $860.06B | $878.73B | $897.40B | $977.91B |
| EBITDA Avg | $471.43B | $328.25B | $228.94B | $276.54B | $282.67B | $288.81B | $294.94B | $321.40B |
| Low | $471.43B | $328.25B | $228.94B | $276.54B | $282.67B | $288.81B | $294.94B | $321.40B |
| High | $471.43B | $328.25B | $228.94B | $276.54B | $282.67B | $288.81B | $294.94B | $321.40B |
| EBIT Avg | $286.28B | $199.33B | $139.03B | $167.93B | $171.66B | $175.38B | $179.11B | $195.18B |
| Low | $286.28B | $199.33B | $139.03B | $167.93B | $171.66B | $175.38B | $179.11B | $195.18B |
| High | $286.28B | $199.33B | $139.03B | $167.93B | $171.66B | $175.38B | $179.11B | $195.18B |
| Net Income Avg | $271.45B | $164.28B | $75.12B | $112.01B | $114.50B | $116.98B | $120.07B | $130.12B |
| Low | $271.45B | $164.28B | $75.12B | $112.01B | $114.50B | $116.98B | $120.07B | $130.12B |
| High | $271.45B | $164.28B | $75.12B | $112.01B | $114.50B | $116.98B | $120.07B | $130.12B |
| EPS Avg | $249.89 | $151.23 | $69.15 | $103.11 | $105.40 | $107.69 | $110.53 | $119.79 |
| Low | $249.89 | $151.23 | $69.15 | $103.11 | $105.40 | $107.69 | $110.53 | $119.79 |
| High | $249.89 | $151.23 | $69.15 | $103.11 | $105.40 | $107.69 | $110.53 | $119.79 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |